ニュージャージーにおける膠腫の臨床試験
ニュージャージー内の拠点で、膠腫に関する10件の研究が参加者を募集しています。
ニュージャージー内の都市
公式研究テキスト（英語）
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Hackensack University Medical Center, Hackensack
- Morristown Medical Center, Morristown
- Newark Beth Israel Medical Center, Newark
- 他1件
被験者募集中第1/2相
12 Months – 21 Years · 全性別 · 2026/10/01更新 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute, New Brunswick
- Atlantic Health, Summit
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566A Study of Mirdametinib in People With Central Nervous System Tumors
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07539441Glioma Developmental and HyperActive Ras Tumor (DHART) Board
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/31更新 · NCT05489783SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Rutgers Cancer Institute, New Brunswick
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack
被験者募集中第1相
1歳〜25歳 · 全性別 · 2026/08/18更新 · NCT04485559A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05188508A Study of 177Lu-PSMA-617 in People With Gliomas
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/04更新 · NCT07223034Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
- Hackensack Meridian Health, Inc, Edison
被験者募集中第1/2相
18歳以下 · 全性別 · 2025/11/20更新 · NCT04299191ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。